Mainz Biomed N.V. (MYNZ)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 16.41M |
| Enterprise value | 16.76M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 13.60 |
| Price/book (mrq) | 5.05 |
| Enterprise value/revenue | 18.72 |
| Enterprise value/EBITDA | -0.68 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.24 |
| 52-week change 3 | -84.60% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 6.0000 |
| 52-week low 3 | 0.7350 |
| 50-day moving average 3 | 0.9725 |
| 200-day moving average 3 | 1.9189 |
Share statistics
| Avg vol (3-month) 3 | 104.56k |
| Avg vol (10-day) 3 | 224.85k |
| Shares outstanding 5 | 21.89M |
| Implied shares outstanding 6 | 21.89M |
| Float 8 | 18.39M |
| % held by insiders 1 | 21.63% |
| % held by institutions 1 | 1.06% |
| Shares short (15 Apr 2024) 4 | 301.54k |
| Short ratio (15 Apr 2024) 4 | 5.38 |
| Short % of float (15 Apr 2024) 4 | 1.64% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.38% |
| Shares short (prior month 15 Mar 2024) 4 | 317.05k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,068.71% |
Management effectiveness
| Return on assets (ttm) | -93.42% |
| Return on equity (ttm) | -303.20% |
Income statement
| Revenue (ttm) | 895.48k |
| Revenue per share (ttm) | 0.05 |
| Quarterly revenue growth (yoy) | 11.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -26.07M |
| Net income avi to common (ttm) | -26.3M |
| Diluted EPS (ttm) | -1.6200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 7.07M |
| Total cash per share (mrq) | 0.32 |
| Total debt (mrq) | 7.42M |
| Total debt/equity (mrq) | 228.39% |
| Current ratio (mrq) | 0.97 |
| Book value per share (mrq) | 0.15 |
Cash flow statement
| Operating cash flow (ttm) | -21.94M |
| Levered free cash flow (ttm) | -13.61M |
© 2024 Yahoo. All rights reserved.